About Pieter Wyckmans

Pieter Wyckmans provides expert advice to companies and organisations active in the (bio-)pharmaceutical, biotech and smart devices sectors and co-heads the life sciences department of QUINZ. Pieter’s transactional expertise covers the entire life cycle of a drug product, including M&A, product divestments and licensing deals. Pieter has a strong regulatory expertise under EU and national laws. Pieter provides his clients with advice on a broad array of legal and strategic issues regarding clinical development and market access, including early access programmes, pricing and reimbursement. Pieter worked in-house for the legal department of UCB.